Dual effect of chemokine CCL7/MCP-3 in the development of renal tubulointerstitial fibrosis.

[1]  Takahiro Matsumoto,et al.  Differential role of regulatory T cells in early and late stages of pulmonary fibrosis. , 2013, Immunobiology.

[2]  Gang Xu,et al.  CD4+ T Lymphocytes, Especially Th2 Cells, Contribute to the Progress of Renal Fibrosis , 2012, American Journal of Nephrology.

[3]  Yi Fang,et al.  The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  G. Arteel,et al.  Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism , 2012, Experimental biology and medicine.

[5]  J. Renauld,et al.  Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis. , 2011, American journal of respiratory and critical care medicine.

[6]  R. Mason,et al.  Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells in vivo. , 2011, Matrix biology : journal of the International Society for Matrix Biology.

[7]  Qincheng He,et al.  CD4+CD25+Foxp3+ Regulatory T Cells Depletion May Attenuate the Development of Silica-Induced Lung Fibrosis in Mice , 2010, PloS one.

[8]  Liping Huang,et al.  Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. , 2010, Kidney international.

[9]  M. Dockrell,et al.  Connective Tissue Growth Factor-(CTGF, CCN2) – A Marker, Mediator and Therapeutic Target for Renal Fibrosis , 2009, Nephron Experimental Nephrology.

[10]  Youhua Liu,et al.  Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. , 2009, Kidney international.

[11]  J. Schanstra,et al.  Delayed Treatment with Plasminogen Activator Inhibitor-1 Decoys Reduces Tubulointerstitial Fibrosis , 2009, Experimental biology and medicine.

[12]  Liping Huang,et al.  Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. , 2009, Journal of the American Society of Nephrology : JASN.

[13]  V. Aidinis,et al.  Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[14]  B. Thornhill,et al.  Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. , 2009, Kidney international.

[15]  M. T. Grande,et al.  Fibroblast activation and myofibroblast generation in obstructive nephropathy , 2009, Nature Reviews Nephrology.

[16]  D. Abraham,et al.  Cross-talk between MCP-3 and TGFbeta promotes fibroblast collagen biosynthesis. , 2009, Experimental cell research.

[17]  J. Schanstra,et al.  Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  T. Yoo,et al.  MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells. , 2008, American journal of physiology. Renal physiology.

[19]  K. Hamaoka,et al.  Macrophage Phenotype and Renal Fibrosis in Obstructive Nephropathy , 2008, Nephron Experimental Nephrology.

[20]  F. Sallusto,et al.  Chemokines and leukocyte traffic , 2008, Nature Immunology.

[21]  M. Mack,et al.  Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. , 2007, The Journal of clinical investigation.

[22]  I. Shiraishi,et al.  MMP-2 inhibition reduces renal macrophage infiltration with increased fibrosis in UUO. , 2007, Biochemical and biophysical research communications.

[23]  P. McCarthy,et al.  Monocyte Chemotactic Protein‐3 Is a Myocardial Mesenchymal Stem Cell Homing Factor , 2007, Stem cells.

[24]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[25]  Jean-Loup Bascands,et al.  Obstructive nephropathy: insights from genetically engineered animals. , 2005, Kidney international.

[26]  I. Shiraishi,et al.  Adoptive transfer of macrophages ameliorates renal fibrosis in mice. , 2005, Biochemical and biophysical research communications.

[27]  N. Wahab,et al.  TGF-β1-Induced Connective Tissue Growth Factor (CCN2) Expression in Human Renal Proximal Tubule Epithelial Cells Requires Ras/MEK/ERK and Smad Signalling , 2005, Nephron Experimental Nephrology.

[28]  D. Harris,et al.  The role of tubulointerstitial inflammation. , 2005, Kidney international. Supplement.

[29]  B. Antus,et al.  Inhibition of Matrix Metalloproteinases During Chronic Allograft Nephropathy in Rats , 2005, Transplantation.

[30]  Yasunori Iwata,et al.  Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. , 2004, Journal of the American Society of Nephrology : JASN.

[31]  D. Abraham,et al.  Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse. , 2003, Arthritis and rheumatism.

[32]  P. Carmeliet,et al.  Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.

[33]  M. Linton,et al.  Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. , 2002, The Journal of clinical investigation.

[34]  S. Klahr,et al.  Obstructive nephropathy and renal fibrosis. , 2002, American journal of physiology. Renal physiology.

[35]  H. Anders,et al.  Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. , 2001, Journal of the American Society of Nephrology : JASN.

[36]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[37]  R. Doms,et al.  CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999, Blood.

[38]  F. Thaiss,et al.  Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-β , 1999 .

[39]  A. Mantovani,et al.  The chemokine system: redundancy for robust outputs. , 1999, Immunology today.

[40]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[41]  S. Phan,et al.  Costimulation of Fibroblast Collagen and Transforming Growth Factor β1 Gene Expression by Monocyte Chemoattractant Protein-1 via Specific Receptors* , 1996, The Journal of Biological Chemistry.

[42]  Margaret Jones,et al.  Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies. , 1993, Journal of immunology.

[43]  G. Opdenakker,et al.  Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family , 1992, The Journal of experimental medicine.

[44]  R. Atkins,et al.  Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. , 2006, Kidney international.

[45]  W. Qi,et al.  The renal cortical fibroblast in renal tubulointerstitial fibrosis. , 2006, The international journal of biochemistry & cell biology.

[46]  J. Van Damme,et al.  Monocyte chemotactic protein-3. , 2001, European cytokine network.

[47]  F. Thaiss,et al.  Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-beta. , 1999, Kidney international.

[48]  M. Haine,et al.  Van Damme A. , 1986 .